🟢 LifeMD is trading 8.2% up in after-hours trading with no clear catalyst identified

LifeMD is trading 8.2% up at $3.73 after rising from the August 14 regular-session close of $3.45, with no clear catalyst identified.

• No credible August 14 company-specific announcement or late-breaking catalyst was identified.
• The latest earnings release was August 5; revenue missed expectations and full-year guidance was reduced, making it too stale to clearly explain the after-hours gain.
• Broader markets were essentially flat, with no clear global-market driver evident.